Yuspa S H, Lichti U, Ben T
Proc Natl Acad Sci U S A. 1980 Sep;77(9):5312-6. doi: 10.1073/pnas.77.9.5312.
The induction of ornithine decarboxylase (L-ornithine carboxy-lyase, EC 4.1.1.17) activity in mouse epidermal cells in vivo and in vitro occurs rapidly after exposure to the tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA). This induction has characteristics of a cell surface receptor-mediated process. Local anesthetics modify a variety of cellular responses mediated by membrane receptors. When cultured mouse epidermal cells were exposed to the local anesthetics lidocaine, tetracaine, or procaine (0.1-1 mM), induction of the decarboxylase by TPA was inhibited by more than 90%. In vivo, lidocaine essentially abolishes the decarboxylase response of mouse epidermis when applied shortly after TPA. In contrast, local anesthetics have no effect on the enzyme's activity when added directly to the assay mixture and, in concert with TPA, have only a minimal effect on overall protein synthesis relative to controls. However, lidocaine has no effect on TPA-stimulated DNA synthesis in vitro (12-fold with or without lidocaine). Local anesthetics also markedly inhibit induction of the decarboxylase by ultraviolet light, which is probably not membrane mediated. Furthermore, in culture, lidocaine has only a small inhibitory effect on ornithine decarboxylase when given before TPA but is an effective inhibitor even when given up to 4-5 hr after the promoter, a time when decarboxylase activity has already increased. These findings suggest that local anesthetics, which are tertiary amines, do not act at the site of interaction of TPA and its putative receptor but may be acting specifically on polyamine biosynthesis. These drugs could be useful agents to determine the role of the polyamine pathway in tumor promotion.
在体内和体外,小鼠表皮细胞在暴露于肿瘤促进剂12 - O - 十四烷酰佛波醇13 - 乙酸酯(TPA)后,鸟氨酸脱羧酶(L - 鸟氨酸羧基裂解酶,EC 4.1.1.17)活性迅速诱导产生。这种诱导具有细胞表面受体介导过程的特征。局部麻醉药可改变由膜受体介导的多种细胞反应。当培养的小鼠表皮细胞暴露于局部麻醉药利多卡因、丁卡因或普鲁卡因(0.1 - 1 mM)时,TPA对脱羧酶的诱导作用被抑制超过90%。在体内,TPA给药后不久应用利多卡因,可基本消除小鼠表皮的脱羧酶反应。相比之下,当直接添加到测定混合物中时,局部麻醉药对该酶的活性没有影响,并且与TPA一起,相对于对照组,对整体蛋白质合成仅有最小的影响。然而,利多卡因对体外TPA刺激的DNA合成没有影响(无论有无利多卡因,均增加12倍)。局部麻醉药也显著抑制紫外线对脱羧酶的诱导作用,紫外线诱导可能不是由膜介导的。此外,在培养中,TPA给药前给予利多卡因对鸟氨酸脱羧酶仅有较小的抑制作用,但即使在启动子给药后4 - 5小时给予,此时脱羧酶活性已经增加,利多卡因仍是一种有效的抑制剂。这些发现表明,作为叔胺的局部麻醉药并非作用于TPA及其假定受体的相互作用位点,而是可能特异性作用于多胺生物合成。这些药物可能是确定多胺途径在肿瘤促进中作用的有用试剂。